Publications

  1. Blair JE, Chang YH, Cheng MR, Vaszar LT, Vikram HR, Orenstein R, Kusne S, Ho S, Seville MT, Parish JM. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014 Jun; 20(6):983-90.
    View PubMed
  2. Orenstein R, Griesbach CL, DiBaise JK. Moving fecal microbiota transplantation into the mainstream. Nutr Clin Pract. 2013 Oct; 28(5):589-98. Epub 2013 Aug 26.
    View PubMed
  3. Azadeh N, Chang YH, Kusne S, Vikram HR, Seville MT, Orenstein R, Blair JE. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis. J Infect. 2013 Aug; 67(2):148-55. Epub 2013 Apr 6
    View PubMed
  4. Patel NC, Griesbach CL, DiBaise JK, Orenstein R. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience. Mayo Clin Proc. 2013 Aug; 88(8):799-805.
    View PubMed
  5. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control. 2013 May; 41(5):390-3.
    View PubMed
  6. Virk A, Mandrekar J, Berbari EF, Boyce TG, Fischer PR, Kasten MJ, Orenstein R, Rosenblatt JE, Sampathkumar P, Sia I, Springer D, Witzig TE. A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea. J Travel Med. 2013 Mar-Apr; 20(2):88-94. Epub 2013 Jan 25.
    View PubMed
  7. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012 Jan; 107(1):89-95. Epub 2011 Nov 22.
    View PubMed
  8. Gallegos-Orozco JF, Paskvan-Gawryletz CD, Gurudu SR, Orenstein R. Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis. Rev Gastroenterol Mex. 2012 Jan-Mar; 77(1):40-2.
    View PubMed
  9. Aronhalt K, McManus J, Orenstein R, Faller R, Link M. Patient and Environmental Service Employee Satisfaction of Using Germicidal Bleach Wipes for Patient Room Cleaning. Journal for Healthcare Quality. 2012.
  10. Orenstein R, Aronhalt KC, McManus JE Jr, Fedraw LA. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol. 2011 Nov; 32(11):1137-9. Epub 2011 Oct 06.
    View PubMed
  11. Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL. Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009. BMC Infect Dis. 2011; 11:145. Epub 2011 May 23.
    View PubMed
  12. Kamal A, Orenstein R. Disseminated sporotrichosis. J Hosp Med. 2010 Mar; 5(3):E29-30.
    View PubMed
  13. Drage LA, Ecker PM, Orenstein R, Phillips PK, Edson RS. An outbreak of Mycobacterium chelonae infections in tattoos. J Am Acad Dermatol. 2010 Mar; 62(3):501-6. Epub 2009 Sep 06.
    View PubMed
  14. Orenstein R, Litin SC. Clinical pearls in infectious diseases. Mayo Clin Proc. 2010 Feb; 85(2):172-5.
    View PubMed
  15. Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. 2010 Jan; 9(1):55-66. Epub 2009 Nov 27.
    View PubMed
  16. Verdoorn BP, Orenstein R, Rosenblatt JE, Sloan LM, Schleck CD, Harmsen WS, Nyre LM, Patel R. High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis. 2010 Jan; 66(1):24-8. Epub 2009 Sep 23
    View PubMed
  17. Verdoorn BP, Orenstein R, Wilson JW, Estes LL, Wendt RF, Schleck CD, Harmsen WS, Nyre LM, Patel R. Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapy. Infect Control Hosp Epidemiol. 2008 Jul; 29(7):658-60.
    View PubMed
  18. Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008 Apr; 134(4):929-36. Epub 2008 Jan 11.
    View PubMed
  19. Mauermann ML, Klein CJ, Orenstein R, Dyck PJ. Disseminated sporotrichosis presenting with granulomatous inflammatory multiple mononeuropathies. Muscle Nerve. 2007 Dec; 36(6):866-72.
    View PubMed
  20. Claassen DO, Batsis JA, Orenstein R. Proteus mirabilis: a rare cause of infectious endocarditis. Scand J Infect Dis. 2007; 39(4):373-5.
    View PubMed
  21. Orenstein R, Matteson EL. Opportunistic infections associated with TNF-alpha treatment. Future Rheumatology. 2007; 2(6):567-76.
    View PubMed
  22. Uslan DZ, Jacobson KM, Kumar N, Berbari EF, Orenstein R. A woman with fever and rash after African safari. Clin Infect Dis. 2006 Sep 1; 43(5):609, 661-2.
    View PubMed
  23. Kumar N, Orenstein R, Uslan DZ, Berbari EF, Klein CJ, Windebank AJ. Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis. Neurology. 2006 Apr 11; 66(7):1120-1. Epub 2006 Mar 15.
    View PubMed
  24. Eid AJ, Orenstein R. Metabolic and morphologic complications of HIV infection. J Med Liban. 2006 Apr-Jun; 54(2):97-105.
    View PubMed
  25. Orenstein R, Matteson EL. TNF inhibitors and infections... tumor necrosis factor. Infections in Medicine. 2006 Mar; 23(3):99-102, 109-14.
    View PubMed
  26. Orenstein R. Infections related to TNF-alpha inhibitors. Expert Reviews in Dermatology. 2006; 1(5):737-749.
  27. Orenstein R. Andrew Taylor Still and the Mayo brothers: convergence and collaboration in 21st-century osteopathic practice. J Am Osteopath Assoc. 2005 May; 105(5):251-4.
    View PubMed
  28. Orenstein R. Travel in patients receiving TNF-alpha inhibitors. Travel Medicine & Infectious Disease. 2005; 3(2):105-9.
    View PubMed
  29. Prabhu RM, Bonnell M, Currier BL, Orenstein R. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004 Oct 1; 39(7):E74-7.
    View PubMed
  30. Orenstein R, Tsogas N. Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection. Pharmacotherapy. 2002 Nov; 22(11):1468-78.
    View PubMed
  31. Orenstein R. Presenting syndromes of human immunodeficiency virus. Mayo Clin Proc. 2002 Oct; 77(10):1093-102; quiz 1102.
    View PubMed
  32. Orenstein R. Hepatitis C - HIV co-infection in women. Symposia on GI disorders in women. J Am Osteo Assoc. 2001 Dec; 101(12):S1-7.
  33. Orenstein R, Tsogas N. Hepatitis C virus and human immunodeficiency virus co-infection in women. J Am Osteopath Assoc. 2001 Dec; 101(12 Suppl Pt 2):S1-6.
    View PubMed
  34. Orenstein R. Preventing antiviral resistance, ramifications. Richmond Academy of Medicine Special Edition on Antimicbrobial Resistance. 2001 Sept; 13(14):9-10.
  35. Bhatia A, Forman S, Orenstein R, Nunley JR, Rowe DR. Molluscum contagiosum. E-Medicine. 2001.
  36. LeGall-Salmon E, Orenstein R. Doxycycline for switch therapy in community acquired pneumonia. Infect Dis Clin Pract. 1999 Dec.
  37. Orenstein R, LeGall-Salmon E. HIV-treatment associated hepatitis. MedScape HIV/AIDS. 1999 Oct.
  38. Link K, Orenstein R. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J. 1999 Jul; 92(7):728-31.
    View PubMed
  39. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician. 1999 Mar 1; 59(5):1225-34, 1237.
    View PubMed
  40. Orenstein R, Wong ES. Management of urinary tract infections. American Fam Phys. 1999; 59:1225-37.
  41. Orenstein R. The benefits and limitations of needle protectors and needleless intravenous systems. Journal of Intravenous Nursing. 1999; 22:122-8.
    View PubMed
  42. Link K, Orenstein R. Complications of strongyloidiasis: streptococcus bovis meningitis. South Med. 1999; 92:728-31.
  43. Orenstein R, LeGall-Salmon E. HIV-treatment associated hepatitis. AIDS Reader. 1999; 9:339-47.
    View PubMed
  44. Foxx-Orenstein AE, Orenstein R. Antibiotics and pancreatitis. Gastroenterologist. 1997; 5:157-64.
    View PubMed
  45. Orenstein R, Karabaic M, Reynolds L, Lamb A, Markowitz SM, Wong ES. Are protective devices effective at preventing needlestick injuries among healthcare workers? Am J Infect Control. 1995; 23:322-30.
    View PubMed
  46. Orenstein R, Wong ES. Complications of antimicrobial therapy in the urologic patient. American Urological Association Update Series. 1994.
  47. Orenstein R. Candidemia following candiduria: not so benign and not so delayed. Clin Infect Dis. 1994; 19:207-8.
    View PubMed
  48. Orenstein R, Dahlman M, Bross JE. Risk factors for urinary lithotripsy - associated sepsis. Infect Control Hosp Epidemiol. 1993; 14:469-72.
    View PubMed